Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
Status:
Unknown status
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study involves a 7 week dose-response trial of Concerta™ methylphenidate for mothers of
children with ADHD who have ADHD themselves. The aim of this study is to assess the efficacy
of Concerta™ in improving adult ADHD symptoms and impairments (primary outcome), as well as
observed and reported parenting (secondary outcome). The researchers hypothesize that
Concerta™ will significantly decrease mothers ADHD symptoms and impairment, as well as
improve observed and reported parenting
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, College Park
Collaborators:
Children's National Research Institute Children's Research Institute McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.